Article Text

Download PDFPDF
CASE REPORT
Near death by milk of magnesia
  1. Ahmed Alaini1,
  2. Carlos A Roldan2,3,
  3. Karen Servilla1,4,
  4. Elizabeth Sage Colombo1,5
  1. 1Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA
  2. 2Department of Cardiology, Univ New Mexico, Albuquerque, New Mexico, USA
  3. 3Department of Cardiology, Veterans Health Administration, Albuquerque, New Mexico, USA
  4. 4Department of Nephrology, Veterans Health Administration, Albuquerque, New Mexico, USA
  5. 5Department of Internal Medicine, Veterans Health Administration, Albuquerque, New Mexico, USA
  1. Correspondence to Dr Elizabeth Sage Colombo, ecolombo{at}salud.unm.edu

Summary

We report a case of hypermagnesemia associated with the use of milk of magnesia in a male patient with end-stage renal disease. After experiencing nausea and vomiting, he developed severe bradycardia and then asystole. Resuscitation efforts were successful; however, he developed atrial fibrillation with severe widening of the QRS and diffuse ST elevation, hypothermia, hypotension and apnoea requiring intubation. Initial diagnoses included ST-elevation myocardial infarction, cardiogenic and/or septic shock and hyperkalaemia. However, serum magnesium was later found to be >4.1 mmol/L (equivalent to >10 mg/dL). He underwent haemodialysis (HD) to remove serum magnesium with remarkable overall improvement. Severe hypermagnesemia can manifest with severe bradycardia and asystole, shock, hypothermia and respiratory failure and can mimic acute coronary syndromes complicated with cardiogenic shock or septic shock. Therefore, clinicians should be aware of this life-threatening condition in patients with significant renal dysfunction. Timely treatment with HD is highly effective and lifesaving.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors Each of the above authors contributed significantly to the writing and editing of this manuscript. The finalised manuscript was approved by each author prior to submission.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.